5 Takeaways From FDA's Biosimilars Promotion Guidance
On April 24, the U.S. Food and Drug Administration released a revised draft guidance regarding promotional labeling and advertising considerations for prescription biological reference products, biosimilar products and interchangeable biosimilar products....To view the full article, register now.
Already a subscriber? Click here to view full article